OHSU

Suman Malempati, M.D.

Head Shot of Suman Malempati

Assistant Professor

Email: 
click here
Office: 
503 346-0640 or 877 346-0640

Background

Dr. Malempati's primary research interest is in the evaluation of novel anti-cancer agents for the treatment of pediatric sarcomas through early phase clinical trials. He is director of the Doernbecher Children's Hospital Developmental Therapeutics program and is involved in design and conduct of clinical trials through the Children's Oncology Group.


Selected Publications

"Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group," Pediatric Blood and Cancer (Vol: 61, Issue: 3, Page 452-456) - 2014

"Overcoming autopsy barriers in pediatric cancer research," Pediatric Blood and Cancer (Vol: 60, Issue: 2, Page 204-209) - 2013

"Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study," Pediatric Blood and Cancer (Vol: 60, Issue: 2, Page 237-241) - 2013

"18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models," Pediatric Blood and Cancer (Vol: 59, Issue: 3, Page 485-492) - 2012

"Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: A report from the Children's Oncology Group," Journal of Clinical Oncology (Vol: 30, Issue: 3, Page 256-262) - 2012

 

Back to faculty list

OHSU Doernbecher Children's Hospital

Visit Our Site

For Healthcare Professionals


Contact

  Email Suman Malempati

503 346-0640 or 877 346-0640

Memberships & Associations

  • Fellow, American Academy of Pediatrics
  • American Society of Hematology
  • American Society of Clinical Oncology
  • American Society of Pediatric Hematology/Oncology
  • Children’s Oncology Group
  • Histiocyte Society
  • Oregon Medical Assiociation